Multi-tissue network analysis for drug prioritization in knee osteoarthritis

Area of Science:

• Biomedical Engineering
• Computational Biology
• Genomics

Background:

• Knee osteoarthritis (OA) is a complex joint disease affecting multiple tissues, with poorly understood pathophysiology.
• Current pharmaceutical treatments for OA primarily focus on pain relief, lacking disease-modifying strategies.

Purpose of the Study:

• To develop a computational method for identifying shared molecular mechanisms across different tissues affected by knee OA.
• To leverage these identified mechanisms for the discovery and prioritization of novel pharmaceutical compounds for OA treatment.

Main Methods:

• Weighted Gene Co-expression Network Analysis (WGCNA) was employed to identify gene modules consistently present across cartilage, synovium, meniscus, and subchondral bone.
• Driver genes from preserved modules were used as input for a network-based drug discovery approach.

Main Results:

• Two preserved gene modules were identified, associated with extracellular matrix physiology and immune system responses.
• The computational method suggested compounds targeting anti-inflammatory and coagulation pathways.
• Nine of the top ten suggested compounds demonstrated a known association with OA and outperformed non-WGCNA methods.

Conclusions:

• The developed computational strategy effectively identifies overlapping molecular mechanisms in multi-tissue diseases like knee OA.
• This approach offers a viable method for drug discovery and compound prioritization in complex diseases.